Generic Name : Azilsartan medoxomil Pronunciation : AY-zil-SAR-tan me-DOX-oh-mil Therapeutic Classification : Anti- Hypertensives And ACE Inhibitors ICD Code : Y52.4♦ Safety Labeling Changes Approved By FDA
International- Edarbi. Why it is prescribed (Indications) :
This medication is an angiotensin II receptor antagonist, prescribed for hypertension. It improves blood flow by widening blood vessels. When it is not to be taken (Contraindications): ♦ Contraindicated during second or third trimester of pregnancy, diabetes, and known hypersensitivity.
Dosage & When it is to be taken :
PO- The recommended dose in adults is 80 mg taken once daily. How it should be taken :
It comes as a tablet to take by mouth, with or without food. Warnings and Precautions :
* Caution should be exercised in patients with history of blood vessel problems, poor blood circulation, heart, liver, or kidney disease, sugar, stroke, heart attack, dehydration, angioedema, low blood volume, any allergy, who are taking other medications, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery and get up slowly from bed while taking this medication.
* Monitor blood pressure, blood electrolyte levels, and heart or kidney function regularly while taking this medication. Side Effects :
Most Common - Low blood pressure.
Gastrointestinal - Nausea.
General - Weakness and fatigue.
Musculoskeletal - Muscle spasm.
Central Nervous System - Dizziness.
Respiratory - Cough.
* Avoid excess dosage. Storage Conditions :
Store it at room temperature (25°C), and in an airtight container. Protect from moisture and light.
Comment & Contribute
Ask an Expert